Trial · NCT07890220
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Cumulative Intravenous Fentanyl Consumption | 48 hours after surgery | Total cumulative dose of intravenous fentanyl administered during the first 48 hours after surgery, including continuous infusion and any additional rescue doses. Fentanyl consumption will be normalized to body weight and expressed as micrograms per kilogram (µg/kg). |
| Secondary | Postoperative Pain Intensity | 6 hours after surgery | Postoperative pain intensity will be assessed using the Numeric Rating Scale (NRS; 0-10), where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity. |
| Secondary | Postoperative Pain Intensity | 12 hours after surgery | Postoperative pain intensity will be assessed using the Numeric Rating Scale (NRS; 0-10), where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity. |
| Secondary | Postoperative Pain Intensity | 24 hours after surgery | Postoperative pain intensity will be assessed using the Numeric Rating Scale (NRS; 0-10), where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity. |
| Secondary | Postoperative Pain Intensity | 48 hours after surgery | Postoperative pain intensity will be assessed using the Numeric Rating Scale (NRS; 0-10), where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity. |
| Secondary | Cumulative Rescue Fentanyl Consumption | 48 hours after surgery | Total cumulative dose of additional intravenous fentanyl administered as rescue analgesia in addition to the continuous fentanyl infusion. Rescue fentanyl consumption will be normalized to body weight and expressed as micrograms per kilogram (µg/kg). |
| Secondary | Number of Rescue Fentanyl Doses | 48 hours after surgery | Number of additional intravenous fentanyl rescue doses administered for inadequate postoperative analgesia during the first 48 hours after surgery. |
| Secondary | Postoperative Nausea and Vomiting | 48 hours after surgery | Occurrence of postoperative nausea and/or vomiting during the first 48 hours after surgery. The need for rescue antiemetic medication will also be recorded. |
| Secondary | Perioperative Blood Glucose Concentration | 48 hours | Blood glucose concentration will be measured to assess dexamethasone-associated perioperative hyperglycemia. Glucose concentration will be recorded in mg/dL. |
| Secondary | Perioperative Blood Glucose Concentration | 12 hours | Blood glucose concentration will be measured to assess dexamethasone-associated perioperative hyperglycemia. Glucose concentration will be recorded in mg/dL. |
| Secondary | Perioperative Blood Glucose Concentration | 6 hours | Blood glucose concentration will be measured to assess dexamethasone-associated perioperative hyperglycemia. Glucose concentration will be recorded in mg/dL. |
| Secondary | Incidence of Adverse Events | 48 hours | Occurrence of adverse events potentially related to intravenous dexamethasone, bilateral ESP block, or postoperative analgesic treatment, including clinically significant hyperglycemia, neurological complications, local anesthetic systemic toxicity, respiratory depression, or other unexpected adverse events. |
| Secondary | Postoperative Opioid-Induced Sedation | 24 hours after surgery | Postoperative sedation will be assessed using the Pasero Opioid-Induced Sedation Scale (POSS), which categorizes the level of sedation from S (sleeping, easy to arouse) and 1 (awake and alert) to 4 (somnolent, minimal or no response to stimulation). Higher numeric scores indicate greater opioid-induced sedation. |
| Secondary | Postoperative Opioid-Induced Sedation | 48 hours after surgery | Postoperative sedation will be assessed using the Pasero Opioid-Induced Sedation Scale (POSS), which categorizes the level of sedation from S (sleeping, easy to arouse) and 1 (awake and alert) to 4 (somnolent, minimal or no response to stimulation). Higher numeric scores indicate greater opioid-induced sedation. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07890220/registered